Metagenomi (Metagenomi) ROCE % : -36.25% (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Metagenomi ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Metagenomi's annualized ROCE % for the quarter that ended in Mar. 2024 was -36.25%.

Metagenomi ROCE % Historical Data

The historical data trend for Metagenomi's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi ROCE % Chart

Metagenomi Annual Data

Trend

Dec21

Dec22

Dec23

ROCE %

-18.10

-16.95

-18.20

Metagenomi Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial				-19.61	-8.26	-22.49	-21.60	-36.25

Metagenomi ROCE % Calculation

Metagenomi's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-60.228	/	( ( (414.486 - 48.537)	+	(364.842 - 68.861) )	/ 2 )
	=	-60.228	/	( (365.949	+	295.981)	/ 2 )
	=	-60.228	/	330.965
	=	-18.20 %

Metagenomi's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-116.128	/	( ( (364.842 - 68.861)	+	(415.403 - 70.701) )	/ 2 )
	=	-116.128	/	( ( 295.981	+	344.702 )	/ 2 )
	=	-116.128	/	320.3415
	=	-36.25 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Metagenomi (NAS:MGX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Metagenomi ROCE % Related Terms

Thank you for viewing the detailed overview of Metagenomi's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Metagenomi (Metagenomi) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Metagenomi (Metagenomi) Headlines

From GuruFocus

Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

By Marketwired • 05-01-2024